Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Axial Spondyloarthritis: Patient-Reported Impact in Europe

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Publication Information:
      Cham: Springer Nature; Springer International Publishing, 2022.
    • Publication Date:
      2022
    • Collection:
      Books
      Imported or submitted locally
    • Original Material:
      76442d97-c19b-40bc-bce6-cadffdcb8a8e
      6c6992af-b843-4f46-859c-f6e9998e40d5
    • Abstract:
      This open access book provides an overview of the International Map of Axial Spondyloarthritis (IMAS) project -focusing on Europe-, a wide-ranging, multi-disciplinary collaboration between academic groups, Health Care Professionals (HCPs), patient organizations and Novartis. IMAS was conceived to improve knowledge of Axial Spondyloarthritis (axSpA) and raise awareness of its heavy burden globally. By asking more than 2,000 patients across Europe about the impact of axSpA on multiple aspects of their life, the full extent of this disease was investigated from a direct patient perspective. This allowed a unique understanding of how living with axSpA affects the daily lives and well-being of patients, and how this varies between European countries. Axial Spondyloarthritis: Patient-Reported Impact in Europe highlights opportunities for progressing quality patient care to be applied to health services globally. HCPs, policy makers and patients will find this book to be an indispensable resource for improving the understanding of this chronic condition, including patients’ clinical outcomes, the protection of those at risk of psychological distress, and the economic burden on patients and society.
    • Contents Note:
      ...
    • File Description:
      application/pdf
    • ISBN:
      978-3-030-97606-4
      3-030-97606-8
    • Accession Number:
      10.1007/978-3-030-97606-4
    • Rights:
      URL: http://creativecommons.org/licenses/by/4.0/
    • Notes:
      ONIX_20220915_9783030976064_17

      https://library.oapen.org/handle/20.500.12657/58361

      https://link.springer.com/978-3-030-97606-4

      Novartis
    • Accession Number:
      edsoap.20.500.12657.58361